|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cooper WA, Lam DC, O'Toole SA and Minna
JD: Molecular biology of lung cancer. J Thorac Dis. 5 Suppl
5:S479–S490. 2013.PubMed/NCBI
|
|
4
|
Hong WK, Bast RC, Hait WN, Kufe DW,
Pollock RE, Weichselbaum RR, Holland JE and Frei E: Chapter 78:
Cancer of the Lung. People's Medical Publishing House; 2010
|
|
5
|
Glisovic T, Bachorik JL, Yong J and
Dreyfuss G: RNA-binding proteins and post-transcriptional gene
regulation. FEBS Lett. 582:1977–1986. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mueller CF, Berger A, Zimmer S, Tiyerili V
and Nickenig G: The heterogenous nuclear riboprotein S1-1 regulates
AT1 receptor gene expression via transcriptional and
posttranscriptional mechanisms. Arch Biochem Biophys. 488:76–82.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y, Gogol-Döring A, Hu H, Fröhler S,
Ma Y, Jens M, Maaskola J, Murakawa Y, Quedenau C, Landthaler M, et
al: Integrative analysis revealed the molecular mechanism
underlying RBM10-mediated splicing regulation. EMBO Mol Med.
5:1431–1442. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pan Q, Shai O, Lee LJ, Frey BJ and
Blencowe BJ: Deep surveying of alternative splicing complexity in
the human transcriptome by high-throughput sequencing. Nat Genet.
40:1413–1415. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
David CJ and Manley JL: Alternative
pre-mRNA splicing regulation in cancer: Pathways and programs
unhinged. Genes Dev. 24:2343–2364. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sutherland LC, Thibault P, Durand M,
Lapointe E, Knee JM, Beauvais A, Kalatskaya I, Hunt SC, Loiselle
JJ, Roy JG, et al: Splicing arrays reveal novel RBM10 targets,
including SMN2 pre-mRNA. BMC Mol Biol. 18:192017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ji Y, Xie S, Jiang L, Liu L, Li L, Luo L,
Chen Y, Zhang J, Yu L, Zhang Y, et al: Increased cell apoptosis in
human lung adenocarcinoma and in vivo tumor growth inhibition by
RBM10, a tumor suppressor gene. Oncol Lett. 14:4663–4669. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hernández J, Bechara E, Schlesinger D,
Delgado J, Serrano L and Valcárcel J: Tumor suppressor properties
of the splicing regulatory factor RBM10. RNA Biol. 13:466–472.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Witkiewicz AK, McMillan EA, Balaji U, Baek
G, Lin WC, Mansour J, Mollaee M, Wagner KU, Koduru P, Yopp A, et
al: Whole-exome sequencing of pancreatic cancer defines genetic
diversity and therapeutic targets. Nat Commun. 6:67442015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cancer Genome Atlas Research Network:
Comprehensive molecular profiling of lung adenocarcinoma. Nature.
511:543–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Imielinski M, Berger AH, Hammerman PS,
Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M,
Sivachenko A, et al: Mapping the hallmarks of lung adenocarcinoma
with massively parallel sequencing. Cell. 150:1107–1120. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ganti AK, Huang CH, Klein MA, Keefe S and
Kelley MJ: Lung cancer management in 2010. Oncology (Williston
Park). 25:64–73. 2011.PubMed/NCBI
|
|
17
|
Westhoff B, Colaluca IN, D'Ario G,
Donzelli M, Tosoni D, Volorio S, Pelosi G, Spaggiari L, Mazzarol G,
Viale G, et al: Alterations of the Notch pathway in lung cancer.
Proc Natl Acad Sci USA. 106:22293–22298. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Johnston JJ, Teer JK, Cherukuri PF, Hansen
NF, Loftus SK; NIH Intramural Sequencing Center (NISC), ; Chong K,
Mullikin JC and Biesecker LG: Massively parallel sequencing of
exons on the X chromosome identifies RBM10 as the gene that causes
a syndromic form of cleft palate. Am J Hum Genet. 86:743–748. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao J, Sun Y, Huang Y, Song F, Huang Z,
Bao Y, Zuo J, Saffen D, Shao Z, Liu W and Wang Y: Functional
analysis reveals that RBM10 mutations contribute to lung
adenocarcinoma pathogenesis by deregulating splicing. Sci Rep.
7:404882017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kaida D, Schneider-Poetsch T and Yoshida
M: Splicing in oncogenesis and tumor suppression. Cancer Sci.
103:1611–1616. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Israels LG and Israels ED: Apoptosis.
Oncologist. 4:332–339. 1999.PubMed/NCBI
|
|
23
|
Inoue A, Yamamoto N, Kimura M, Nishio K,
Yamane H and Nakajima K: RBM10 regulates alternative splicing. FEBS
Lett. 588:942–947. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma K, Fan Y, Dong X, Dong D, Guo Y, Wei X,
Ning J, Geng Q, Wang C, Hu Y, et al: MTA1 promotes epithelial to
mesenchymal transition and metastasis in non-small-cell lung
cancer. Oncotarget. 8:38825–38840. 2017.PubMed/NCBI
|
